Russian innovation helps perform prostate cancer surgeries
30 Jan '15
Irkutsk surgeons in Siberia have begun treating prostate cancer, applying the method of brachytherapy which uses innovative microsources made in Russia, portal Nanonewsnet.ru reported. In the recent past, such surgeries in Russia have been successfully performed in Krasnoyarsk, Novosibirsk and Tyumen—also in Siberia—as well as in Ufa, in the West Urals.
This has been made possible after Russia’s pioneering and still only production site was launched last summer in Dubna outside Moscow to make microsources for low-dose brachytherapy.
Brachytherapy is a modern high-tech type of radiotherapy for a range of cancers, including prostate cancer, which is believed to minimize possible harm to a patient during treatment, as curative isotopes are delivered directly into a tumor, sparing the organs and tissues that surround it.
Prostate cancer is one of the oncology cases most widespread among Russian men; about 14,000 new cases are diagnosed each year in this country. Around the world, the brachytherapy method is widely used in an estimated 800 medical centers in the United States and Western Europe.